BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tesarova B, Musilek K, Rex S, Heger Z. Taking advantage of cellular uptake of ferritin nanocages for targeted drug delivery. Journal of Controlled Release 2020;325:176-90. [DOI: 10.1016/j.jconrel.2020.06.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Krausova K, Charousova M, Kratochvil Z, Takacsova P, Tesarova B, Sivak L, Peskova MK, Sukupova M, Zivotska H, Makovicky P, Yamashita I, Okamoto N, Hynek D, Haddad Y, Pekarik V, Rex S, Heger Z. Toward understanding the kinetics of disassembly of ferritins of varying origin and subunit composition. Applied Materials Today 2022;28:101535. [DOI: 10.1016/j.apmt.2022.101535] [Reference Citation Analysis]
2 Hou S, Hasnat M, Chen Z, Liu Y, Faran Ashraf Baig MM, Liu F, Chen Z. Application Perspectives of Nanomedicine in Cancer Treatment. Front Pharmacol 2022;13:909526. [DOI: 10.3389/fphar.2022.909526] [Reference Citation Analysis]
3 Mohanty A, Parida A, Raut RK, Behera RK. Ferritin: A Promising Nanoreactor and Nanocarrier for Bionanotechnology. ACS Bio Med Chem Au 2022;2:258-81. [DOI: 10.1021/acsbiomedchemau.2c00003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zivotska H, Mokry M, Rodrigo MAM, Michalkova H, Kapolkova K, Splichal Z, Stokowa-soltys K, Milosavljevic V, Guran R, Richtera L, Haddad Y, Rex S, Heger Z. Conotoxin-derived biomimetic coiled cone-shaped peptide as ligand for selective nanodelivery to norepinephrine transporter-expressing neuroblastoma cells. Applied Materials Today 2022;27:101410. [DOI: 10.1016/j.apmt.2022.101410] [Reference Citation Analysis]
5 Sun B, Wu F, Wang X, Song Q, Ye Z, Mohammadniaei M, Zhang M, Chu X, Xi S, Zhou N, Wang W, Yao C, Shen J. An Optimally Designed Engineering Exosome-Reductive COF Integrated Nanoagent for Synergistically Enhanced Diabetic Fester Wound Healing. Small 2022;:e2200895. [PMID: 35638464 DOI: 10.1002/smll.202200895] [Reference Citation Analysis]
6 Rawal SU, Patel BM, Patel MM. New Drug Delivery Systems Developed for Brain Targeting. Drugs 2022. [PMID: 35596879 DOI: 10.1007/s40265-022-01717-z] [Reference Citation Analysis]
7 Feng C, Li Y, Ferdows BE, Patel DN, Ouyang J, Tang Z, Kong N, Chen E, Tao W. Emerging vaccine nanotechnology: From defense against infection to sniping cancer. Acta Pharm Sin B 2022;12:2206-23. [PMID: 35013704 DOI: 10.1016/j.apsb.2021.12.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Xu X, Tian K, Lou X, Du Y. Potential of Ferritin-Based Platforms for Tumor Immunotherapy. Molecules 2022;27:2716. [DOI: 10.3390/molecules27092716] [Reference Citation Analysis]
9 Cheng P, Han H, Chen F, Cheng L, Ma C, Huang H, Chen C, Li H, Cai H, Huang H, Li G, Tao J. Amelioration of acute myocardial infarction injury through targeted ferritin nanocages loaded with an ALKBH5 inhibitor. Acta Biomater 2022;140:481-91. [PMID: 34879293 DOI: 10.1016/j.actbio.2021.11.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhu Y, Jin D, Liu M, Dai Y, Li L, Zheng X, Wang L, Shen A, Yu J, Wu S, Wu Y, Zhong K, Cheng J, Liu Y. Oxygen Self-Supply Engineering-Ferritin for the Relief of Hypoxia in Tumors and the Enhancement of Photodynamic Therapy Efficacy. Small 2022;:e2200116. [PMID: 35212462 DOI: 10.1002/smll.202200116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kim NH, Choi H, Shahzad ZM, Ki H, Lee J, Chae H, Kim YH. Supramolecular assembly of protein building blocks: from folding to function. Nano Converg 2022;9:4. [PMID: 35024976 DOI: 10.1186/s40580-021-00294-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yazdian-Robati R, Bayat P, Dehestani S, Hashemi M, Taghdisi SM, Abnous K. Smart delivery of epirubicin to cancer cells using aptamer-modified ferritin nanoparticles. J Drug Target 2022;:1-12. [PMID: 34991424 DOI: 10.1080/1061186X.2022.2025600] [Reference Citation Analysis]
13 Conti G, Pitea M, Ossanna R, Opri R, Tisci G, Falvo E, Innamorati G, Ghanem E, Sbarbati A, Ceci P, Fracasso G. Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model. Biomedicines 2021;9:1622. [PMID: 34829851 DOI: 10.3390/biomedicines9111622] [Reference Citation Analysis]
14 Zhang J, Cheng D, He J, Hong J, Yuan C, Liang M. Cargo loading within ferritin nanocages in preparation for tumor-targeted delivery. Nat Protoc 2021;16:4878-96. [PMID: 34497386 DOI: 10.1038/s41596-021-00602-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Zhang B, Tang G, He J, Yan X, Fan K. Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrier. Adv Drug Deliv Rev 2021;176:113892. [PMID: 34331986 DOI: 10.1016/j.addr.2021.113892] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
16 Rafipour R, Mousavi A, Mansouri K. Apoferritin nanocages for targeted delivery of idarubicin against breast cancer cells. Biotechnol Appl Biochem 2021. [PMID: 33929766 DOI: 10.1002/bab.2177] [Reference Citation Analysis]
17 Tang C. Strategies to utilize naturally occurring protein architectures as nanovehicles for hydrophobic nutraceuticals. Food Hydrocolloids 2021;112:106344. [DOI: 10.1016/j.foodhyd.2020.106344] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
18 Silva F, Sitia L, Allevi R, Bonizzi A, Sevieri M, Morasso C, Truffi M, Corsi F, Mazzucchelli S. Combined Method to Remove Endotoxins from Protein Nanocages for Drug Delivery Applications: The Case of Human Ferritin. Pharmaceutics 2021;13:229. [PMID: 33562060 DOI: 10.3390/pharmaceutics13020229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Skubalova Z, Rex S, Sukupova M, Zahalka M, Skladal P, Pribyl J, Michalkova H, Weerasekera A, Adam V, Heger Z. Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System. Int J Nanomedicine 2021;16:1-14. [PMID: 33442247 DOI: 10.2147/IJN.S275808] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Iqbal H, Yang T, Li T, Zhang M, Ke H, Ding D, Deng Y, Chen H. Serum protein-based nanoparticles for cancer diagnosis and treatment. J Control Release 2021;329:997-1022. [PMID: 33091526 DOI: 10.1016/j.jconrel.2020.10.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]